An Application of a Large‐Scale, Data‐Driven Approach to Prioritize Compound‐Targeted Conditions in the Nutraceutical Space: Case Study of Quercefit TM (Quercetin Phytosome) Toward Unbalanced Lipid Conditions in Metabolically Challenged Adults
Molecular Nutrition & Food Research · 2025
DOI: 10.1002/mnfr.70253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2025. Verfasst von Loukia Lili und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Thorne HealthTech, Inc., NYC, New York, USA. Hauptthemen laut MEDLINE: Quercetin, Dietary Supplements. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Indena SpA and Thorne HealthTech, Inc.
Abstract (Originalsprache)
In preventive healthcare, the demand for systematic identification of wellness‐promoting natural compounds is rising. Quercetin, a phenolic compound found in various fruits and vegetables, is known for its antioxidant and anti‐inflammatory properties, improving lipid profiles and metabolic dysfunctions in conditions like Type 2 diabetes and NAFLD. This study applies a novel adaptation of an in‐silico drug repurposing methodology to quercetin, analyzing a gene expression signature library of over 800 diseases and 30 quercetin‐related conditions to prioritize molecular targets. Our findings revealed a strong computational link between quercetin and hypercholesterolemia. To validate this, we conducted a proof‐of‐concept clinical study using a high‐bioaccessibility quercetin formulation (Quercefit TM ) in healthy adults with borderline metabolic profiles, confirming health benefits. This study highlights quercetin's known potential in managing hypercholesterolemia and demonstrates the power of computational methods in advancing natural compound discovery and repositioning. The integration of in‐silico predictions with human studies could pave the way for more precise or alternative use of bioactive compounds in dietary supplements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research and Development, Thorne HealthTech, Inc., NYC, New York, USA.
- Research and Development, Indena SpA, Milan, Italy.
- ASU-Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, Arizona, USA.
ORCID-Profile: Loukia Lili
Förderung
- Indena SpA and Thorne HealthTech, Inc
Zitieren
APA
Lili, L., Smith, S., Kunces, L., Antonella, R., Allegrini, P., Togni, S., Tongiani, S., Rickard, N., Readhead, B., Phipps, S., & Zhang, B. (2025). An Application of a Large‐Scale, Data‐Driven Approach to Prioritize Compound‐Targeted Conditions in the Nutraceutical Space: Case Study of Quercefit TM (Quercetin Phytosome) Toward Unbalanced Lipid Conditions in Metabolically Challenged Adults. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70253
Vancouver
Lili L, Smith S, Kunces L, Antonella R, Allegrini P, Togni S, et al. An Application of a Large‐Scale, Data‐Driven Approach to Prioritize Compound‐Targeted Conditions in the Nutraceutical Space: Case Study of Quercefit TM (Quercetin Phytosome) Toward Unbalanced Lipid Conditions in Metabolically Challenged Adults. Molecular Nutrition & Food Research. 2025. doi:10.1002/mnfr.70253
BibTeX
@article{Lili2025,
author = {Lili, Loukia and Smith, Sheena and Kunces, Laura and Antonella, Riva and Allegrini, Pietro and Togni, Stefano and Tongiani, Serena and Rickard, Nate and Readhead, Benjamin and Phipps, Stephen and Zhang, Bodi},
title = {An Application of a Large‐Scale, Data‐Driven Approach to Prioritize Compound‐Targeted Conditions in the Nutraceutical Space: Case Study of Quercefit TM (Quercetin Phytosome) Toward Unbalanced Lipid Conditions in Metabolically Challenged Adults},
journal = {Molecular Nutrition & Food Research},
year = {2025},
doi = {10.1002/mnfr.70253}
}
EUVIMED